You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 4, April 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (112)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fluorouracil As an Adjuvant to Surgery in Carcinoma of the Colon

George A. Higgins, MD; Richard W. Dwight, MD; John V. Smith, MD; Robert J. Keehn

AMA Arch Surg. 1971;102(4):339-343.


Abstract

A group of 496 patients was entered into a randomized trial to study the possible value of fluorouracil in conjunction with surgical resection of carcinoma of the colon. Patients randomized to receive drug were given fluorouracil, 12 mg/kg body weight intravenously, for five successive days beginning 14 days after operation. Those termed clinically "curative" (A) and those termed clinically palliative (C) received a second course of drug six weeks later. Those termed proved palliative (B) continued to receive an intermittent course of fluorouracil. At 41/2 years postrandomization, life table survival in group A, "currative resection," is 56% in treated patients and 50% in controls. Survival at 18 months in group B is 30% in treated vs 16% in controls, and group C, 57% in treated vs 31% in controls. While these results are encouraging, sufficient numbers of patients have not been followed up for a long enough period to justify valid evidence of drug benefit.



Author Affiliations

Washington, DC; Boston; Martinez, Calif; Washington, DC

From the Veterans Administration Surgical Adjuvant Group, Veterans Administration Hospital, Washington, DC.


Footnotes

Accepted for publication Dec 15, 1970.

Read before the 78th annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 19, 1970.

Reprint requests to 50 Irving St NW, Washington, DC 20422 (Dr. Higgins).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effects of Perioperative Fluorouracil Administration on Convalescence and Wound Healing
Klausner et al.
Arch Surg 1986;121:239-242.
ABSTRACT  

Multimodal Primary Cancer Treatment (Adjuvant Chemotherapy): Current Results and Future Prospects
WEISS and DeVITA
ANN INTERN MED 1979;91:251-260.
ABSTRACT  

Early Detection and Prevention of Colon Cancer: The Role of Colonoscopy
Skibba et al.
Arch Intern Med 1976;136:890-892.
ABSTRACT  

Chemoprophylaxis for Patients With Colorectal Cancer: Prospective Study With Five-Year Follow-Up
Li and Ross
JAMA 1976;235:2825-2828.
ABSTRACT  

Progress in the Treatment of Colorectal Cancer
Mavligit and Freireich
JAMA 1976;235:2855-2855.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.